ADAM10 and central nervous system cancer: The expression of ADAM10 was significantly elevated in low-grade glioma samples compared with the control group (meningioma), while being further increased in high-grade glioma samples, which may suggest that mRNA and protein expression levels of ADAM10 are closely associated with glioma grade in a malignancy-dependent pattern [60].